Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Rosuvastatin (Crestor) raises HbA1c by roughly 0.1 to 0.3 percentage points in most patients. Learn the mechanism, which patients are at highest risk, and how to monitor safely.
Read clinical reviewRosuvastatin can raise ALT in a small percentage of patients. Learn the magnitude, time course, mechanism, monitoring schedule, and when ALT elevation on Crestor requires action.
Read clinical reviewRosuvastatin lowers apolipoprotein B (ApoB) by 33 to 50% depending on dose. Learn the clinical evidence from JUPITER, STELLAR, and guidelines on when to check ApoB while taking Crestor.
Read clinical reviewEvidence-based guide on rosuvastatin's effect on AST liver enzymes, including expected changes, monitoring timelines, when to worry, and what clinical trials show about Crestor and hepatotoxicity risk.
Read clinical review